Cargando…

Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment

BACKGROUND: As Traditional Chinese Medicine (TCM) drugs, Huangqi and Danshen are always applied in combination for spinal cord injury (SCI) treatment based on the compatibility theory of TCM. Astragalus Polysaccharidesis (APS) and Tanshinone IIA (TSIIA) are the main active ingredients of Huangqi and...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Siyuan, Lin, Yongpeng, Lin, Rui, Liu, Jinggong, Wang, Hongshen, Hu, Weixiong, Chen, Bolai, Chen, Tianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195429/
https://www.ncbi.nlm.nih.gov/pubmed/35701758
http://dx.doi.org/10.1186/s12951-022-01490-x
_version_ 1784726963376619520
author Rao, Siyuan
Lin, Yongpeng
Lin, Rui
Liu, Jinggong
Wang, Hongshen
Hu, Weixiong
Chen, Bolai
Chen, Tianfeng
author_facet Rao, Siyuan
Lin, Yongpeng
Lin, Rui
Liu, Jinggong
Wang, Hongshen
Hu, Weixiong
Chen, Bolai
Chen, Tianfeng
author_sort Rao, Siyuan
collection PubMed
description BACKGROUND: As Traditional Chinese Medicine (TCM) drugs, Huangqi and Danshen are always applied in combination for spinal cord injury (SCI) treatment based on the compatibility theory of TCM. Astragalus Polysaccharidesis (APS) and Tanshinone IIA (TSIIA) are the main active ingredients of Huangqi and Danshen, and they both possess neuroprotective effects through antioxidant activities. However, low solubility and poor bioavailability have greatly limited their application. In recent years, selenium nanoparticles (SeNPs) have drawn enormous attention as potential delivery carrier for antioxidant drugs. RESULTS: In this study, TCM active ingredients-based SeNPs surface decorated with APS and loaded with TSIIA (TSIIA@SeNPs-APS) were successfully synthesized under the guidance of the compatibility theory of TCM. Such design improved the bioavailability of APS and TSIIA with the benefits of high stability, efficient delivery and highly therapeutic efficacy for SCI treatment illustrated by an improvement of the antioxidant protective effects of APS and TSIIA. The in vivo experiments indicated that TSIIA@SeNPs-APS displayed high efficiency of cellular uptake and long retention time in PC12 cells. Furthermore, TSIIA@SeNPs-APS had a satisfactory protective effect against oxidative stress-induced cytotoxicity in PC12 cells by inhibiting excessive reactive oxygen species (ROS) production, so as to alleviate mitochondrial dysfunction to reduce cell apoptosis and S phase cell cycle arrest, and finally promote cell survival. The in vivo experiments indicated that TSIIA@SeNPs-APS can protect spinal cord neurons of SCI rats by enhancing GSH-Px activity and decreasing MDA content, which was possibly via the metabolism of TSIIA@SeNPs-APS to SeCys(2) and regulating antioxidant selenoproteins to resist oxidative stress-induced damage. CONCLUSIONS: TSIIA@SeNPs-APS exhibited promising therapeutic effects in the anti-oxidation therapy of SCI, which paved the way for developing the synergistic effect of TCM active ingredients by nanotechnology to improve the efficacy as well as establishing novel treatments for oxidative stress-related diseases associated with Se metabolism and selenoproteins regulation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01490-x.
format Online
Article
Text
id pubmed-9195429
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91954292022-06-15 Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment Rao, Siyuan Lin, Yongpeng Lin, Rui Liu, Jinggong Wang, Hongshen Hu, Weixiong Chen, Bolai Chen, Tianfeng J Nanobiotechnology Research BACKGROUND: As Traditional Chinese Medicine (TCM) drugs, Huangqi and Danshen are always applied in combination for spinal cord injury (SCI) treatment based on the compatibility theory of TCM. Astragalus Polysaccharidesis (APS) and Tanshinone IIA (TSIIA) are the main active ingredients of Huangqi and Danshen, and they both possess neuroprotective effects through antioxidant activities. However, low solubility and poor bioavailability have greatly limited their application. In recent years, selenium nanoparticles (SeNPs) have drawn enormous attention as potential delivery carrier for antioxidant drugs. RESULTS: In this study, TCM active ingredients-based SeNPs surface decorated with APS and loaded with TSIIA (TSIIA@SeNPs-APS) were successfully synthesized under the guidance of the compatibility theory of TCM. Such design improved the bioavailability of APS and TSIIA with the benefits of high stability, efficient delivery and highly therapeutic efficacy for SCI treatment illustrated by an improvement of the antioxidant protective effects of APS and TSIIA. The in vivo experiments indicated that TSIIA@SeNPs-APS displayed high efficiency of cellular uptake and long retention time in PC12 cells. Furthermore, TSIIA@SeNPs-APS had a satisfactory protective effect against oxidative stress-induced cytotoxicity in PC12 cells by inhibiting excessive reactive oxygen species (ROS) production, so as to alleviate mitochondrial dysfunction to reduce cell apoptosis and S phase cell cycle arrest, and finally promote cell survival. The in vivo experiments indicated that TSIIA@SeNPs-APS can protect spinal cord neurons of SCI rats by enhancing GSH-Px activity and decreasing MDA content, which was possibly via the metabolism of TSIIA@SeNPs-APS to SeCys(2) and regulating antioxidant selenoproteins to resist oxidative stress-induced damage. CONCLUSIONS: TSIIA@SeNPs-APS exhibited promising therapeutic effects in the anti-oxidation therapy of SCI, which paved the way for developing the synergistic effect of TCM active ingredients by nanotechnology to improve the efficacy as well as establishing novel treatments for oxidative stress-related diseases associated with Se metabolism and selenoproteins regulation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01490-x. BioMed Central 2022-06-14 /pmc/articles/PMC9195429/ /pubmed/35701758 http://dx.doi.org/10.1186/s12951-022-01490-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rao, Siyuan
Lin, Yongpeng
Lin, Rui
Liu, Jinggong
Wang, Hongshen
Hu, Weixiong
Chen, Bolai
Chen, Tianfeng
Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment
title Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment
title_full Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment
title_fullStr Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment
title_full_unstemmed Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment
title_short Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment
title_sort traditional chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195429/
https://www.ncbi.nlm.nih.gov/pubmed/35701758
http://dx.doi.org/10.1186/s12951-022-01490-x
work_keys_str_mv AT raosiyuan traditionalchinesemedicineactiveingredientsbasedseleniumnanoparticlesregulateantioxidantselenoproteinsforspinalcordinjurytreatment
AT linyongpeng traditionalchinesemedicineactiveingredientsbasedseleniumnanoparticlesregulateantioxidantselenoproteinsforspinalcordinjurytreatment
AT linrui traditionalchinesemedicineactiveingredientsbasedseleniumnanoparticlesregulateantioxidantselenoproteinsforspinalcordinjurytreatment
AT liujinggong traditionalchinesemedicineactiveingredientsbasedseleniumnanoparticlesregulateantioxidantselenoproteinsforspinalcordinjurytreatment
AT wanghongshen traditionalchinesemedicineactiveingredientsbasedseleniumnanoparticlesregulateantioxidantselenoproteinsforspinalcordinjurytreatment
AT huweixiong traditionalchinesemedicineactiveingredientsbasedseleniumnanoparticlesregulateantioxidantselenoproteinsforspinalcordinjurytreatment
AT chenbolai traditionalchinesemedicineactiveingredientsbasedseleniumnanoparticlesregulateantioxidantselenoproteinsforspinalcordinjurytreatment
AT chentianfeng traditionalchinesemedicineactiveingredientsbasedseleniumnanoparticlesregulateantioxidantselenoproteinsforspinalcordinjurytreatment